Arcturus Therapeutics Holdings (ARCT) Short-term Investments (2023 - 2025)

Arcturus Therapeutics Holdings has reported Short-term Investments for 3 years, with the latest figure at $55.0 million in Q3 2025.

• For the quarter ending Q3 2025, Short-term Investments changed 0.0% year-over-year to $55.0 million; the trailing twelve-month figure through Sep 2025 stood at $55.0 million (changed 0.0% YoY), and the FY2024 full-year result was $55.0 million, changed 0.0% from the prior year.
• Short-term Investments for Q3 2025 stood at $55.0 million, roughly flat from $55.0 million in the prior quarter.
• The five-year high for Short-term Investments was $55.0 million in Q4 2023, with the low at $38.5 million in Q1 2025.
• Historically, Short-term Investments has averaged $52.9 million across 3 years, with a median of $55.0 million in 2023.
• Annual changes were most pronounced in 2024 — Short-term Investments changed 0.0% — and 2025, when it tumbled 30.0%.
• Arcturus Therapeutics Holdings' Short-term Investments stood at $55.0 million in 2023, then changed by 0.0% to $55.0 million in 2024, then changed by 0.0% to $55.0 million in 2025.
• The last three Short-term Investments figures came in at $55.0 million (Q3 2025), $55.0 million (Q2 2025), and $38.5 million (Q1 2025), per Business Quant data.